Health Condition 1: C109- Malignant neoplasm of oropharynx,unspecified
Conditions
Interventions
Intervention1: Lignocaine 2% and 4%: at the times of intubation 24hrs
Control Intervention1: comparison time of intubation Lignocaine 2% and 4%: time of intubation at 24hrs
Sponsors
Department of Anaesthesiology and Intensive Care Unit
Eligibility
Inclusion criteria
Inclusion criteria: Patients giving written informed consent. Aged between 18-60 years of both sex. American Society of Anaesthesiologists grading of I and II. Patients having Mallampati grading of 3 and 4 and or mouth opening less than 2 fingers. Patients with anticipated difficult airway undergoing elective dental and surgical oncology procedures
Exclusion criteria
Exclusion criteria: Any type of A-V block on electrocardiogram (ECG), heart failure, coronary heart disaese. Liver cirrhosis, thrombocytopenia and coagulopathies. Severe bradycardia. Current psychiatric disorder, history of seizures. Any respiratory disorders. History of epistaxis, nasal pathology. Known drug allergy to the study drugs. ASA III and ASA IV. Pregnant females. Emergency procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the ease of intubation ( by patient tolerance, vocal cord movement and cough severity score) between 2 groups receiving 2% lignocaine & receiving 4% lignocaine respectively through spray as you go techniqueTimepoint: To compare the ease of intubation ( by patient tolerance, vocal cord movement and cough severity score) between 2 groups receiving 2% lignocaine & receiving 4% lignocaine respectively through spray as you go technique | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Number of attempts taken for intubation. 2. Total time duration taken for intubation. 3. Total volume of local anaesthetic drug used. 4. Cough severity. 5. Hemodynamic changes during intubation. 6. Adverse events in postoperative period. Timepoint: 1. number of attempts taken for intubation. 2. Total time duration taken for intubation. 3. Total volume of local anaesthetic drug used. 4. Cough severity. 5. Hemodynamic changes during intubation. 6. Adverse events in postoperative period. | — |
Countries
India
Contacts
Public ContactDr Manoj Kumar Chaurasiya
King Georges Medical University Lucknow
Outcome results
None listed